Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-25

Clinical Trial Update: Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating drug-drug interactions between remdesivir and commonly used antiretroviral therapy in Ebola and HIV/AIDS patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remdesivir (remdesivir)

Snippet

Sponsor: Makerere University | Conditions: Ebola, HIV/AIDS | Phase 2 | Status: COMPLETED